QuickView for MIA;jsessionid=32D86F7F5C0A7DD46D523677589E8360;jsessionid=2F125EE0D4A0810FE48BE004EECD3DBC;jsessionid=B092DCC7EC45615BA1EFB89207480F20;jsessionid=EBA0C2B032C7113AC306062E98493224;jsessionid=10AD5FFE571B06B124211171467A61E4 (gene)

1. Chromosome 19q13 disruption alters expressions of CYP2A7, MIA and MIA-RAB4B lncRNA and contributes t…
2. NMR-based Drug Development and Improvement Against Malignant Melanoma - Implications for the MIA Pro…
3. Targeting melanoma metastasis and immunosuppression with a new mode of melanoma inhibitory activity …
4. Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melano…
5. N-extended photoprotein obelin to competitively detect small protein tumor markers.

There were no clinical trials for MIA;jsessionid=32D86F7F5C0A7DD46D523677589E8360;jsessionid=2F125EE0D4A0810FE48BE004EECD3DBC;jsessionid=B092DCC7EC45615BA1EFB89207480F20;jsessionid=EBA0C2B032C7113AC306062E98493224;jsessionid=10AD5FFE571B06B124211171467A61E4